Literature DB >> 12243370

Metformin-associated lactic acidosis: case reports and literature review.

Chin-Tung Chang1, Yung-Chang Chen, Ji-Tseng Fang, Chiu-Ching Huang.   

Abstract

BACKGROUND: Lactic acidosis is a widely recognized, though rare, side effect of metformin. This paper describes five patients admitted to Chang Gung Memorial Hospital from 1 September 1998 to 31 May 2001 suffering severe lactic acidosis caused by metformin, and reviews the literature. PATIENTS: Five cases diagnosed as having meftormin-associated lactic acidosis (MALA) were discovered during the study period. Three had normal renal function before the onset of MALA and two had attempted suicide bytaking large amounts of metformin. One patient with end-stage renal disease developed MALA despite regularhemodialysis three times a week. One of the patients who had taken metformin to attempt suicide was not diabetic.
RESULTS: All patients suffered severe metabolic acidosis with a high anion gap and blood lactate level. Four developed profound hypotension, and three of these also suffered acute respiratory failure. Three patients received conventional hemodialysis and two continuous renal replacement therapy. A young non-diabetic female who had taken a large dose of metformin to commit suicide died from multiple organ failure despite aggressive treatment.
CONCLUSIONS: Lactic acidosis is a serious reaction to metformin, and hemodialysis (the treatment of choice) should be done urgently to prevent serious complications. MALA should be suspected in patients presenting with wide anion gap metabolic acidosis and high blood lactate, even when they are non-diabetic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12243370

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  21 in total

Review 1.  Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Authors:  Lawrence Maayan; Julia Vakhrusheva; Christoph U Correll
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

2.  Metformin's contraindications: needed for now.

Authors:  I George Fantus
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

3.  Acute rhabdomyolysis during treatment with amisulpride and metformin.

Authors:  Francesco Ursini; Elena Succurro; Alessandro Grembiale; Franco Arturi
Journal:  Eur J Clin Pharmacol       Date:  2009-12-18       Impact factor: 2.953

4.  Metformin associated Atrial Fibrillation - A Case Report.

Authors:  Hemant Boolani; David Shanberg; Vineela Chikkam; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2011-09-30

5.  Mimetics of hormetic agents: stress-resistance triggers.

Authors:  Joan Smith Sonneborn
Journal:  Dose Response       Date:  2010-01-06       Impact factor: 2.658

6.  Metformin-related lactic acidosis in patients with acute kidney injury.

Authors:  Vassilios Devetzis; Ploumis Passadakis; Stelios Panagoutsos; Marios Theodoridis; Elias Thodis; Anastasia Georgoulidou; Vassilis Vargemezis
Journal:  Int Urol Nephrol       Date:  2010-09-22       Impact factor: 2.370

7.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

8.  Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study.

Authors:  Alistair D Nichol; Moritoki Egi; Ville Pettila; Rinaldo Bellomo; Craig French; Graeme Hart; Andrew Davies; Edward Stachowski; Michael C Reade; Michael Bailey; David James Cooper
Journal:  Crit Care       Date:  2010-02-24       Impact factor: 9.097

Review 9.  Hyperglycaemic crises and lactic acidosis in diabetes mellitus.

Authors:  P English; G Williams
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

10.  Update on Safety Issues Related to Antihyperglycemic Therapy.

Authors:  Gandahari Rosa A Carpio; Vivian A Fonseca
Journal:  Diabetes Spectr       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.